LOS ANGELES, Aug. 13, 2024 /PRNewswire/ -- Pelage Pharmaceuticals, a clinical-stage regenerative medicine company pioneering a new generation of treatments for hair loss, today announced that the ...
Pelage Pharmaceuticals has raised nearly $17 million in a series A funding round to develop a small-molecule treatment for alopecia and other types of hair loss. The Los Angeles–based biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results